BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 29032273)

  • 1. Torquetenovirus Dynamics and Immune Marker Properties in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective Longitudinal Study.
    Wohlfarth P; Leiner M; Schoergenhofer C; Hopfinger G; Goerzer I; Puchhammer-Stoeckl E; Rabitsch W
    Biol Blood Marrow Transplant; 2018 Jan; 24(1):194-199. PubMed ID: 29032273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Value of Torque Teno Virus (TTV) as a Marker for the Degree of Immunosuppression in Adult Patients after Hematopoietic Stem Cell Transplantation (HSCT).
    Schmitz J; Kobbe G; Kondakci M; Schuler E; Magorsch M; Adams O
    Biol Blood Marrow Transplant; 2020 Apr; 26(4):643-650. PubMed ID: 31712192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of Torque Teno virus plasma DNAemia in allogeneic stem cell transplant recipients.
    Albert E; Solano C; Pascual T; Torres I; Macera L; Focosi D; Maggi F; Giménez E; Amat P; Navarro D
    J Clin Virol; 2017 Sep; 94():22-28. PubMed ID: 28710997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of Torque Teno virus viremia could predict risk of complications after allogeneic hematopoietic stem cell transplantation.
    Gilles R; Herling M; Holtick U; Heger E; Awerkiew S; Fish I; Höller K; Sierra S; Knops E; Kaiser R; Scheid C; Di Cristanziano V
    Med Microbiol Immunol; 2017 Oct; 206(5):355-362. PubMed ID: 28702856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of Alphatorquevirus plasma DNAemia at late times after allogeneic hematopoietic stem cell transplantation.
    Albert E; Solano C; Giménez E; Focosi D; Pérez A; Macera L; Piñana JL; Mateo EM; Boluda JCH; Maggi F; Navarro D
    Med Microbiol Immunol; 2019 Apr; 208(2):253-258. PubMed ID: 30852649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of torque teno virus DNA load in saliva and plasma following allogeneic hematopoietic stem cell transplantation.
    Albert E; Torres I; Talaya A; Giménez E; Piñana JL; Hernández-Boluda JC; Focosi D; Macera L; Maggi F; Solano C; Navarro D
    J Med Virol; 2018 Sep; 90(9):1438-1443. PubMed ID: 29727487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torque Teno Virus Viral Load as a Marker of Immune Function in Allogeneic Haematopoietic Stem Cell Transplantation Recipients.
    Mouton W; Conrad A; Bal A; Boccard M; Malcus C; Ducastelle-Lepretre S; Balsat M; Barraco F; Larcher MV; Fossard G; Labussière-Wallet H; Ader F; Brengel-Pesce K; Trouillet-Assant S; Heminf Study Group L
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33187285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of plasma Torque teno virus, total Anelloviridae and Human Pegivirus 1 viral load for the prediction of infectious events and acute graft versus host disease in the allogeneic hematopoietic stem cell transplantation setting.
    Forqué L; Albert E; Piñana JL; Pérez A; Hernani R; Solano C; Navarro D; Giménez E
    J Med Virol; 2023 Sep; 95(9):e29107. PubMed ID: 37721473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of Torque Teno virus DNA in stools may predict occurrence of acute intestinal graft versus host disease early after allogeneic hematopoietic stem cell transplantation.
    Bueno F; Albert E; Piñana JL; Pérez A; Úbeda C; Gómez MD; Hernández-Boluda JC; Gonzalez-Barberá EM; Montoro J; Giménez E; Guerreiro M; Balaguer-Roselló A; Hernani R; Sanz J; Solano C; Navarro D
    Transpl Infect Dis; 2021 Jun; 23(3):e13507. PubMed ID: 33176050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.
    Albert E; Solano C; Giménez E; Focosi D; Pérez A; Macera L; Piñana JL; Boluda JCH; Maggi F; Navarro D
    Bone Marrow Transplant; 2018 Feb; 53(2):180-187. PubMed ID: 29084205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Torque Teno Virus as a Potential Biomarker for Complications and Survival After Allogeneic Hematopoietic Stem Cell Transplantation.
    Pradier A; Masouridi-Levrat S; Bosshard C; Dantin C; Vu DL; Zanella MC; Boely E; Tapparel C; Kaiser L; Chalandon Y; Simonetta F; Roosnek E
    Front Immunol; 2020; 11():998. PubMed ID: 32536920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of Torque Teno Virus (TTV) DNA as an immunological and virological marker in pediatric hematopoietic stem cell transplantation (HSCT) patients.
    Peker BO; Daloğlu AE; Görzer I; Puchhammer-Stöckl E; Parkan ÖM; Akbaş H; Kintrup GT; Mutlu D; Küpesiz OA; Çolak D
    Microb Pathog; 2020 Dec; 149():104397. PubMed ID: 32707315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Torque Teno Virus Is Associated With the State of Immune Suppression Early After Liver Transplantation.
    Ruiz P; Martínez-Picola M; Santana M; Muñoz J; Pérez-Del-Pulgar S; Koutsoudakis G; Sastre L; Colmenero J; Crespo G; Navasa M
    Liver Transpl; 2019 Feb; 25(2):302-310. PubMed ID: 30375165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Post-Transplant Torquetenovirus Viremia Predicts Cytomegalovirus Reactivations In Solid Organ Transplant Recipients.
    Maggi F; Focosi D; Statzu M; Bianco G; Costa C; Macera L; Spezia PG; Medici C; Albert E; Navarro D; Scagnolari C; Pistello M; Cavallo R; Antonelli G
    Sci Rep; 2018 Oct; 8(1):15490. PubMed ID: 30341363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of Torque Teno viral load with CMV and BKV infection in pediatric and adolescent kidney transplant patients.
    Eibensteiner F; Messner I; Uhl P; Bond G; Puchhammer-Stoeckl E; Mueller-Sacherer T; Aufricht C; Rusai K
    J Clin Virol; 2024 Jun; 172():105673. PubMed ID: 38564881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viruses, friends, and foes: The case of Torque Teno Virus and the net state of immunosuppression.
    Redondo N; Navarro D; Aguado JM; Fernández-Ruiz M
    Transpl Infect Dis; 2022 Apr; 24(2):e13778. PubMed ID: 34933413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of molecular methods for the quantitative measure of torquetenovirus viremia, the new surrogate marker of immune competence.
    Macera L; Spezia PG; Medici C; Rofi E; Del Re M; Focosi D; Mazzetti P; Navarro D; Antonelli G; Danesi R; Pistello M; Maggi F
    J Med Virol; 2022 Feb; 94(2):491-498. PubMed ID: 31002743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Torque teno virus dynamics during the first year of life.
    Tyschik EA; Rasskazova AS; Degtyareva AV; Rebrikov DV; Sukhikh GT
    Virol J; 2018 May; 15(1):96. PubMed ID: 29843750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-transplant plasma Torque Teno virus load and increase dynamics after lung transplantation.
    Görzer I; Jaksch P; Kundi M; Seitz T; Klepetko W; Puchhammer-Stöckl E
    PLoS One; 2015; 10(3):e0122975. PubMed ID: 25894323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Torque teno virus-DNA load as individual cytomegalovirus risk assessment parameter upon allogeneic hematopoietic stem cell transplantation.
    Spiertz A; Tsakmaklis A; Farowski F; Knops E; Heger E; Wirtz M; Kaiser R; Holtick U; Vehreschild MJGT; Di Cristanziano V
    Eur J Haematol; 2023 Dec; 111(6):963-969. PubMed ID: 37772680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.